Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what discussions he has had with NHS England on the availability of bisphosphonates for the prevention of secondary breast cancer.
We have had no such discussions with NHS England. Clinical commissioning groups are responsible for commissioning these drugs for the prevention of secondary breast cancer based upon clinical judgement.